Vanguard Group Inc Evoke Pharma Inc Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Evoke Pharma Inc stock. As of the latest transaction made, Vanguard Group Inc holds 29,851 shares of EVOK stock, worth $14,029. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,851
Previous 29,851
-0.0%
Holding current value
$14,029
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EVOK
# of Institutions
15Shares Held
3.15MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD847KShares$397,8850.16% of portfolio
-
Bleichroeder LP New York, NY825KShares$387,7500.16% of portfolio
-
Altium Capital Management LP New York, NY692KShares$325,4460.19% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT675KShares$317,2500.02% of portfolio
-
Geode Capital Management, LLC Boston, MA49.7KShares$23,3540.0% of portfolio
About Evoke Pharma Inc
- Ticker EVOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,343,070
- Market Cap $1.57M
- Description
- Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...